Market Analysts see VivoSim Labs Inc [VIVS] gaining to $2.50. Time to buy?

Caleb Clifford

VivoSim Labs Inc [NASDAQ: VIVS] gained 29.57% on the last trading session, reaching $2.98 price per share at the time.

VivoSim Labs Inc represents 2.60 million in outstanding shares, while the company has a total market value of $7.75 million with the latest information. VIVS stock price has been found in the range of $2.37 to $3.2.

If compared to the average trading volume of 320.48K shares, VIVS reached a trading volume of 25597207 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about VivoSim Labs Inc [VIVS]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VIVS shares is $64.80 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VIVS stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

H.C. Wainwright have made an estimate for VivoSim Labs Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 13, 2018. The new note on the price target was released on November 10, 2017, representing the official price target for VivoSim Labs Inc stock.

The Price to Book ratio for the last quarter was 0.81, with the Price to Cash per share for the same quarter was set at 3.48.

Trading performance analysis for VIVS stock

VivoSim Labs Inc [VIVS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 35.45. With this latest performance, VIVS shares dropped by -7.17% in over the last four-week period, additionally plugging by 51.27% over the last 6 months – not to mention a drop of -46.00% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VIVS stock in for the last two-week period is set at 55.40, with the RSI for the last a single of trading hit 0.33, and the three-weeks RSI is set at 0.34 for VivoSim Labs Inc [VIVS]. The present Moving Average for the last 50 days of trading for this stock 2.91, while it was recorded at 2.44 for the last single week of trading, and 2.89 for the last 200 days.

VivoSim Labs Inc [VIVS]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and VivoSim Labs Inc [VIVS] shares currently have an operating margin of -8552.82% and a Gross Margin at -83.80%. VivoSim Labs Inc’s Net Margin is presently recorded at -1399.30%.

VivoSim Labs Inc (VIVS) Capital Structure & Debt Analysis

According to recent financial data for VivoSim Labs Inc. ( VIVS), the Return on Equity (ROE) stands at -24.53%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -18.53%, reflecting the company’s efficiency in generating profits from its assets. Additionally, VivoSim Labs Inc’s Return on Invested Capital (ROIC) is -20.20%, showcasing its effectiveness in deploying capital for earnings.

VivoSim Labs Inc (VIVS) Efficiency & Liquidity Metrics

Based on VivoSim Labs Inc’s (VIVS) latest financial statements, the Debt-to-Equity Ratio is 0.09%, indicating its reliance on debt financing relative to shareholder equity.

VivoSim Labs Inc (VIVS) Efficiency & Liquidity Metrics

From an operational efficiency perspective, VivoSim Labs Inc. (VIVS) effectively leverages its workforce, generating an average of -$153076.92 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.52% and a Quick Ratio of 4.52%, indicating strong ability to cover short-term liabilities.

VivoSim Labs Inc [VIVS]: An earnings per share (EPS) analysis

With the latest financial reports released by the company, VivoSim Labs Inc posted -8.04/share EPS, while the average EPS was predicted by analysts to be reported at -5.04/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -3. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VIVS.

An analysis of Institutional ownership at VivoSim Labs Inc [VIVS]

There are presently around $9.02%, or 9.12%% of VIVS stock, in the hands of institutional investors.

DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.